Skip to contentLubner David Charles — TETRAPHASE PHARMACEUTICALS INC insider: 112 transactions · InsiderLensLubner David Charles
- Director at CARGO Therapeutics, Inc. · on record since Nov 13, 2023
- Director at Arcellx, Inc. · on record since Apr 28, 2026
- Director at DYNEGY INC /IL/ · on record since Apr 28, 2026
- SVP and CFO at TETRAPHASE PHARMACEUTICALS INC · on record since Mar 27, 2013
- 10% owner at TETRAPHASE PHARMACEUTICALS INC · on record since Mar 27, 2013
- Director at GLYCOMIMETICS INC · on record since Jun 3, 2026
- Director at KNIGHT CAPITAL GROUP, INC. · on record since Jan 29, 2019
- Executive VP and CFO at Ra Pharmaceuticals, Inc. · on record since Feb 3, 2017
- Director at Therapeutics Acquisition Corp. · on record since Jul 7, 2020
- Director at Disc Medicine, Inc. · on record since Mar 15, 2021
- Director at Vor Biopharma Inc. · on record since Feb 9, 2021
Insider trading activity of Lubner David Charles
- Transactions on record
- 112
- since Mar 27, 2013
- Open-market buys
- 1
- $24.7K
- Open-market sells
- 11
- $3M
- Companies traded
- 10
- last filing Jun 9, 2026
Figures computed from official regulatory filings — methodology.
Companies where Lubner David Charles has traded
- DYNEGY INC /IL/13 tx · $499.8K · Jun 9, 2026
- GLYCOMIMETICS INC2 tx · Jun 3, 2026
- Arcellx, Inc.17 tx · $487.7K · Apr 28, 2026
- CARGO Therapeutics, Inc.4 tx · Aug 19, 2025
- Vor Biopharma Inc.5 tx · May 23, 2025
- Therapeutics Acquisition Corp.9 tx · $24.7K · Dec 27, 2023
- Disc Medicine, Inc.3 tx · Mar 9, 2022
- Ra Pharmaceuticals, Inc.16 tx · $819K · Apr 3, 2020
- KNIGHT CAPITAL GROUP, INC.4 tx · $1.2M · Jun 7, 2019
Track record of Lubner David Charles
Insufficient history for a statistical track record (fewer than 5 open-market buys).
Transaction history of Lubner David Charles
Co-insiders of Lubner David Charles
This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
39 tx · $2.8M · Aug 17, 2015
Novo A/SArcellx, Inc. +2
| Company | Filed | Type | Qty | Price | Value · USD | Src |
|---|
| Jun 9, 2026 | AwardD | 35,152 | 0.00 USD | $0 | SEC |
| Jun 3, 2026 | AwardD | 11,050 | 0.00 USD | $0 | SEC |
| Apr 28, 2026 | OtherD | -31,794 | — | — | SEC |
| Apr 28, 2026 | Other | -21,659 | — | — | SEC |
| Apr 28, 2026 | OtherD | -61,538 | — | — | SEC |
| Apr 28, 2026 | OtherD | -9,174 | — | — | SEC |
| Apr 28, 2026 | OtherD | -59,405 | — | — | SEC |
| Apr 28, 2026 | Gift | -53,625 | 0.00 USD | $0 | SEC |
| Apr 28, 2026 | OtherD | -13,626 | — | — | SEC |
| Apr 28, 2026 | OtherD | -11,459 | — | — | SEC |
| Apr 28, 2026 | OtherD | -8,011 | — | — | SEC |
| Jan 20, 2026 | ExerciseD | -6,000 | 0.00 USD | $0 | SEC |
| Jan 20, 2026 | Sell | -6,000 | 75.00 USD | $450K | SEC |
| Jan 20, 2026 | Exercise | 6,000 | 6.28 USD | $37.7K | SEC |
| Aug 19, 2025 | OtherD | -25,000 | — | — | SEC |
| Jun 23, 2025 | AwardD | 9,023 | 0.00 USD | $0 | SEC |
| Jun 20, 2025 | AwardD | 25,000 | 0.00 USD | $0 | SEC |
| Jun 3, 2025 | AwardD | 35,000 | 0.00 USD | $0 | SEC |
| May 30, 2025 | AwardD | 9,174 | 0.00 USD | $0 | SEC |
| May 23, 2025 | AwardD | 30,000 | 0.00 USD | $0 | SEC |
| Jun 6, 2024 | AwardD | 23,742 | 0.00 USD | $0 | SEC |
| Jun 6, 2024 | AwardD | 8,011 | 0.00 USD | $0 | SEC |
| May 28, 2024 | AwardD | 30,000 | 0.00 USD | $0 | SEC |
| May 24, 2024 | AwardD | 25,133 | 0.00 USD | $0 | SEC |
| Dec 27, 2023 | OtherD | -25,000 | — | — | SEC |